Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
About this item
Full title
Author / Creator
Publisher
Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of potent HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) administered when antiretroviral therapy (ART) was discontinued, but it remains unclear whether bNAbs can target the viral re...
Alternative Titles
Full title
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A573147237
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A573147237
Other Identifiers
ISSN
0028-0836
DOI
10.1038/s41586-018-0600-6
